Hyperalphalipoproteinemia

MONDO:0015903

An autosomal dominant genetic condition caused by mutation(s) in the CETP gene, encoding cholesteryl ester transfer protein. Affected individuals may have increased longevity due to decreased risk of coronary heart disease.

Also known as: HALP1

1 clinical trial for this condition and its sub-types, 0 tagged with Hyperalphalipoproteinemia itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →

Part of

↑ Hyperlipidemia (400) ↑ Hyperlipoproteinemia (106)

Sub-types of Hyperalphalipoproteinemia

Cholesterol-ester transfer protein deficiency 0 trials
Hyperlipidemia due to hepatic triglyceride lipase deficiency 0 trials

Including sub-types (1) Tagged with Hyperalphalipoproteinemia (0)

Not yet finished but already full! 1

New study aims to boost statin use with simple doctor nudges

Disease control Ongoing

This study tests two methods to increase referrals to a centralized pharmacy service for managing statin therapy in patients with or at high risk for heart disease. One method sends reminders to doctors during office visits, and the other sends electronic messages outside of visi…

Sponsor: University of Pennsylvania • Aim: Disease control

Last updated Jun 27, 2026 12:04 UTC

Hyperalphalipoproteinemia

Where it sits in the disease tree

New study aims to boost statin use with simple doctor nudges